Scott Saywell

Scott Saywell is an accomplished executive in the biotechnology and corporate development sectors, currently serving as Executive Vice President of Corporate Development at Coherus BioSciences since December 2023. Saywell has extensive experience in various leadership roles, including as Chief Business Officer at Herophilus, where strategic corporate development activities were spearheaded. As a Trustee for the Menlo Park City School District, Saywell is publicly elected for the terms 2018-2022 and 2022-2026. Earlier positions include Vice President of Corporate Development and Strategy at Theravance Biopharma, with notable transactions involving partnerships with Pfizer and Janssen Biotech. Educational credentials include an MBA from the Kellogg School of Management at Northwestern University and a BS in Physiological Science from UCLA.